Intriguingly, STIM2 protein level—evaluated as a combination of IHC staining intensity and the percentage of positively stained cells—was significantly higher in samples of breast cancer lymph node metastases than in primary breast tumor samples (Fig. 2b). Here, STIM2 is linked to breast neoplasm.